Epistrophy Week Ahead

The Week Of March 30, 2026

A Week Ahead and a day late (better than a dollar short and a day late.) After a big week on the Iberian Peninsula for Epistrophy, we’re following up with a big week on the San Francisco Peninsula, where we’ll be at the Oracle (ORCL:NASDAQ) AI Database Analyst Summit at its sprawling campus in Redwood Shores, CA (and, fun fact, the former Marine World/Africa USA).

The Orca shows are long gone, but we’ll get a better sense of the beast of AI databases, Oracle’s Database 23ai. And of course, the week may well highlight moves by activist investor Elliott Investment Management after taking a stake in the foundational electronic design automation giant Synopsys (SNPS:NASDAQ), a company we know well.

You can find prior notes and the full research archive at https://epistrophy.beehiiv.com.

As always, I’m focused on three things:
1) Technology-driven change;
2) the latest in innovation and startup trends, and;
3) stock fraud.

Companies Discussed

Ticker

Name

Market Cap ($B)

Price

FIX

Comfort Systems USA

$50.26 B

$1,462.23

EME

Emcor Group

$35.94 B

$812.79

PWR

Quanta Services

$82.24 B

$552.66

ACM

Aecom

$12.56 B

$97.89

IFRA

VanEck FTSE Global Infrastructure (Hedged) ETF

-

$25.58

PAVE

Global X U.S. Infra Developments UCITS ETF USD Acc

-

$51.68

HAIL

State Street SPDR S&P Kensho Smart Mobility ETF

-

$35.23

In This Note:

Navitas’ market moving  “unique… new” SiC design, Mar. 11, 2026
Source: Navitas

Navitas’ remarkably similar old SiC design, Jan. 30, 2023
Source: Navitas

Wannabe Chipmakers Old Whine, New Bottles

Navitas Semiconductor (NVTS: NASDAQ) — a company with billions in market cap, millions in revenue and zero in profits — saw its stock get a nice big boost going into the big NVDIA GTC conference in March. There were hopes of a big deal with the computing giant. But there was no deal.

But, as is often the case with wannabe-AI-player Navitas there was a press release.

NVIDIA deal hopes were raised following a press release announcing a “new industry benchmark” in silicon-carbide power semiconductors. In reality, the announcement concerns two packaging formats for its existing GeneSiC MOSFET platform, both built on the same trench-assisted planar SiC architecture the company has already been marketing for several product cycles. The improvements cited in the release focus primarily on packaging geometry and internal figures of merit rather than a clearly new transistor structure, wafer process, or manufacturing node. For a company whose revenue base still measures only in the tens of millions of dollars annually, the language of an industry benchmark appears ambitious relative to its scale in the global SiC market.

The specifications themselves are not unusual. Navitas lists two 1200-V devices with on-resistance of 6.5 mΩ and 12 mΩ, figures well within the existing range of competing parts already sold by far larger silicon-carbide suppliers including Wolfspeed (WOLF: NYSE), onsemi (ON: NASDAQ), STMicroelectronics (STM: NYSE), Infineon Technologies (IFNNY: OTC), and Rohm Semiconductor (6963: TSE). Each of those companies already markets extensive 1200-V SiC MOSFET portfolios and has published product announcements describing existing generations of the technology—for example Wolfspeed’s  Gen-4 SiC MOSFET platform, onsemi’s EliteSiC devices, STMicro’s STPOWER SiC MOSFET family, Infineon’s CoolSiC MOSFET lineup, and Rohm’s fourth-generation SiC MOSFETs.

Stripped of marketing language, the Navitas announcement is largely about packaging. One package routes heat through the top of the device rather than the PCB, while the other reduces the height of the long-standing TO-247 through-hole form factor. Both may offer useful mechanical refinements for dense power systems such as server power supplies. But the press release repeatedly invokes AI data centers, grid electrification, and hyperscale computing—markets already dominated by suppliers with vastly larger manufacturing scale and product portfolios. 

Navitas still doesn’t seem to have an chips coming off the assembly line. After loosing production partner Taiwan Semiconductor last year, it’s pivot to Powership fizzled in January 2026 when Micron captured most of Powerships production. Lacking a more solid update, in February Navitias said a future partnership with GlobalFoundries was only in “development.”

Newly named CEO Chris Allexandre, just eight months on the job, is already selling shares (The stock was $5.76 when he joined. He sold at $8.93. Footnotes say it was a tax-related sale.)

Given Navitas’ limited revenue base and modest shipment history in silicon carbide, a skeptical reader might conclude that the press release reflects more narrative alignment with the AI infrastructure boom than a clear technological step forward.

Tweet O’ The Week

With Schwab Network’s Nicole Petallides. Viewers tweeted that I need shades for my LA rooftop shot (thank you nonetheless Proper Hotel DTLA!)
Source: Schwab Network

Epistrophy In The News

After a fantastic week with both the Nvidia GTC conference in Silicon Valley and the monumental OFC 2026 conference (which we chronicled in “When Elephants Fell In ❤️ With Lasers), I joined Schwab Network’s Nicole Petallides for a special program examining Nvidia's (NVDA) GTC 2026 conference outline its next phase of growth after a wave of recent technical breakthroughs and partnerships, as we looked at which industries stand to gain from rising capital spending (yeah, optical!)

📆 of Epistrophy Events

Ticker

Name

Market Cap

Expected Date

Type

ORCL

AI Database Analyst Summit

$399 B

Mar 31

Conference

CSP

Construction Spending

Apr 1

Economic Event

DG_FULL

Factory Orders (M3 Full Report)

Apr 2

Economic Event

TSLA

Q1 Production & Deliveries

$1,113 B

Apr 2

Press Release

EMPSIT

Employment Situation

Apr 3

Economic Event

🎉

Good Friday

Apr 3

Market Holiday

CPI

Consumer Price Index

Apr 10

Economic Event

PPI

Producer Price Index

Apr 14

Economic Event

ASML

ASML Holding NV

$494 B

Apr 15

Earnings

CRM

TDX 2026

Apr 15

Conference

RS

Advance Retail & Food Services Sales

Apr 16

Economic Event

IP

Industrial Production & Capacity Utilization

Apr 16

Economic Event

NHC

New Residential Construction

Apr 17

Economic Event

Availability This Week

I’ll be down on the Peninsula or in our San Francisco office at the Ferry Building all week and available for TV or calls whenever.

Written reports are available to clients, with video summaries on YouTube, and of course our popular summaries of the summaries on Instagram, TikTok, and YouTube Shorts.

We certify that (1) the views expressed in this report accurately reflect our views about all of the subject companies and securities and (2) no part of my compensation was, is or will be directly related to the specific recommendations or views expressed in this report.

Important disclosures

Important disclosures are available by calling (347) 619-2489 or writing to Epistrophy Capital Research, One Ferry Building, Suite 201, San Francisco, CA 94105.

Epistrophy Capital Research is an independent research provider and does not operate as a financial institution. Epistrophy explicitly does not provide investment advice, stock recommendations, or solicitations to buy or sell any securities.

The research reports provided by Epistrophy Capital Research contain opinions derived from publicly available information, issuer communications, recognized statistical services, and other reputable sources considered reliable. However, Epistrophy does not independently verify the accuracy or completeness of such information and explicitly disclaims responsibility for any errors or omissions.

Opinions and analysis contained within Epistrophy's research reports are current only at the time of publication and are subject to change without notice. Readers must independently verify facts and conduct their own due diligence before making investment decisions.

Epistrophy Capital Research does not consider or evaluate individual investor circumstances, including investment objectives, financial situations, or risk tolerance. Investing in securities, particularly small-cap and micro-cap stocks, involves substantial risks, including significant volatility and potential loss of principal. Readers are strongly advised to consult their financial advisor or another qualified professional before acting on any information provided. Readers should assume Epistrophy Capital Research, its principals or its contributors may have positions, long or short, any of the companies discussed and the Epistrophy Capital Research principals or contributors may have had or currently have business interests in the companies discussed.

Past performance referenced in Epistrophy reports is not indicative of future results. Security prices can fluctuate widely, and investors should be aware that investments can result in significant financial losses. Epistrophy Capital Research or its Unless explicitly stated otherwise, prices quoted in reports reflect market closing prices from the previous trading day.

Epistrophy Capital Research publications are intended solely for direct recipients and should not be redistributed or shared with third parties without explicit permission from Epistrophy Capital Research LLC.

Epistrophy Capital Research reports are provided strictly for informational purposes and do not constitute a comprehensive analysis of any company, security, or industry. No content within these reports should be considered accounting, tax, legal, or professional advice.

Links or references to third-party websites or external resources are provided solely for informational convenience. Epistrophy Capital Research expressly disclaims endorsement of, and responsibility for, the content, accuracy, or reliability of such external information. Accessing third-party information is done entirely at the user's own risk.

For additional details, clarification, or specific inquiries regarding Epistrophy Capital Research reports, please contact Epistrophy Capital Research LLC directly.

Reply

or to participate.